Michael A. Morse

2 ta ish

Duke Medical Center

1. A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer

   Michael A. Morse, Jennifer Garst, Takuya Osada +10

   MaqolaOAOchiq kirish20052 iqtibos

   ABIABI:AkademIndex/2026.other.121737

2. Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study

   Michael J. Overman, Ray McDermott, Joseph L. Leach +13

   MaqolaOAOchiq kirish20172 iqtibos

   ABIABI:AkademIndex/2026.other.241933